Skip to main content
. Author manuscript; available in PMC: 2022 Jun 1.
Published in final edited form as: Hematol Oncol Clin North Am. 2021 Apr 10;35(3):633–653. doi: 10.1016/j.hoc.2021.02.008

Figure 1.

Figure 1.

Oncoprint from The Cancer Genome Atlas (TCGA) depicting the distribution of potentially predictive genomic biomarkers in muscle-invasive bladder cancer.1,106,107 Each column depicts the genomic profile of an individual patient. Y-axis labels include the percentage of muscle-invasive bladder cancers in the TCGA with alterations in each gene. TCGA patients without alterations in one or more of the selected genes are not shown.